In short. Scar and contour work after an occlusion is staged months later, starts from what is left, and promises no restoration. What each option can and cannot change.
Key points
- A scar that is raised and firm, a patch that is darker than the skin around it, a patch that is lighter, and a change in contour where tissue was lost are four different problems, and they are not treated the same way.
- The assessment that precedes treatment is about which of them is present, and how much of it is likely to change on its own first.
Once the emergency phase of an occlusion has passed and the skin has stopped changing, the question patients ask is what can be done about how it looks. The honest answer has three parts: the work is staged months after the event rather than weeks, it starts from what the skin has left rather than from what was there before, and nothing in it promises to restore what was lost. Those limits are not a reason to do nothing. They are the reason the plan is described in stages rather than in outcomes.
Why nothing starts early
Skin that has been through a vascular event is inflamed, its pigment is unstable, and its final colour and texture are not yet established. Treating it during that phase means treating a moving target, and it adds a second injury to tissue still recovering from the first. This is why pigment work and scar work both wait, and why the waiting period is measured in months. The exception is skin that has not yet closed, which is a wound-care problem rather than an aesthetic one.
The plan is built from what is left
A scar that is raised and firm, a patch that is darker than the skin around it, a patch that is lighter, and a change in contour where tissue was lost are four different problems, and they are not treated the same way. The assessment that precedes treatment is about which of them is present, and how much of it is likely to change on its own first.
What is offered, and when
Scar that has matured can often be improved with staged treatment, and the aim is a scar that is softer, flatter and less conspicuous rather than one that is gone. Pigment that has increased usually fades with time and protection, and treatment for what remains is cautious and slow. Pigment that has been lost is the hardest problem here: it frequently does not recover, and the options are limited and partial. Where volume has been lost, it can sometimes be restored in part, into tissue that has already changed.
What cannot be promised
No revision reliably undoes an occlusion. There is no treatment that returns injured skin to the state it was in before, no treatment that brings back pigment that has been lost, and no treatment that restores vision. A patient offered a corrective plan as though it were a restoration is being offered something that does not exist, and the question worth asking is what the plan is expected to change and how that will be judged.
Seek care without delay if
- The area becomes hot, spreading red or swollen, discharges, or you develop a fever.
- The area of changed skin extends, or new blistering or darkening appears.
- There is any new change in vision, or new pain or swelling around the eye.
Bring the record of the original event and the photographs taken since. How the skin behaved in the first weeks is part of what any later plan is built on.
Frequently asked questions
When can something be done about the appearance?
After the skin has settled, which in practice means months rather than weeks. Treating pigment or texture while the area is still changing adds inflammation to tissue that is already inflamed and makes the outcome harder to judge. The first stage is protection, sun cover and review; the staged work comes later and is planned from what the skin has left.
Can the damage be repaired completely?
No. Scars can often be improved and cannot be removed, and skin that has lost its pigment frequently does not recover it. Volume that was lost can sometimes be restored in part, and it is restored into tissue that has changed. Any plan is judged by how much better the area can be made, not by whether it can be returned to its previous state.
Is another injection ever used in a damaged area?
Sometimes, and only once the area has settled and the circulation to it has been assessed. Injecting into skin that has been injured carries its own risk, including the risk of repeating the event, and it is not a first step. Where it is offered it is a deliberate decision made with the history in front of the clinician, not a routine top-up.
Risks & Limitations
- The site of the injection is not the site of the damage: filler that enters an artery is carried by the blood flow and lodges downstream.
- Only a filler of the enzyme-dissolvable class can be dissolved. Biostimulators, polycaprolactone and calcium-based fillers cannot.
- Dissolving the product removes the cause; it does not repair tissue that has already lost its blood supply.
- The glabella, nose, forehead, temple and tear trough share a blood supply with the eye, which is why they are treated with particular care.
- A change in vision after a facial injection is an emergency in which minutes matter, and recovery cannot be assumed.
- Where skin or vision has been lost, later treatment can improve an area but does not restore what was there before.
When to Seek Care
- Severe pain out of proportion to the injection, or pain that keeps worsening — seek emergency care now.
- Skin turning white, grey, mottled or dusky, a lacy or blotchy pattern, or skin that feels cold — seek emergency care now.
- Any change in vision, a drooping eyelid, or pain and swelling around the eye — seek emergency care now; minutes matter.
- Blistering, peeling or darkening skin over a treated area — seek emergency care now.
- A severe headache, or weakness or numbness on one side of the body — seek emergency care now and call emergency services.
- A reaction that is not settling but is not in this list — contact your treating team the same day.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — injectable filler safety guidance
- U.S. Food and Drug Administration (FDA) — dermal filler safety information
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.